RCL vs REPL · P/E 26, rev $16.48B vs $825.7M cap
Royal Caribbean Cruises Ltd (RCL) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported RCL revenue for 2024-12-31 was $16.48B. Net income was $2.90B. Revenue was up 18.6% from 2023-12-31 to 2024-12-31. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
REPL does not have a complete income-statement cache yet.
RCL currently screens at market cap $85.57B and trailing P/E 25.7. REPL currently screens at market cap $825.7M.
Not investment advice. Open the RCL and REPL stock pages for the full models.
Not investment advice.